XML 95 R85.htm IDEA: XBRL DOCUMENT v3.10.0.1
GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION - Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS    
Net cash (used in) provided by operating activities $ 209,482 $ 79,605
Cash flows from investing activities:    
Capital expenditures (196,094) (91,698)
Purchase of short-term investments (31,324) (16,183)
Payment for acquisition of business, net of cash acquired (2,781) (47,832)
Proceeds from sale of short-term investments 31,860 18,120
Proceeds from asset sales 11,609 8,749
Net cash used in investing activities (186,730) (128,844)
Cash flows from financing activities:    
Debt issuance costs paid (3,912)  
Dividends paid (78,122) (76,503)
Payments for employee taxes on net settlement of equity awards (6,267) (5,471)
Proceeds from stock option exercises 1,954 892
Payment of contingent consideration from acquisition of business   (1,500)
Net cash used in financing activities (86,347) (82,582)
Net decrease in cash and cash equivalents and restricted cash (63,595) (131,821)
Cash and cash equivalents and restricted cash, beginning of period 326,185 560,509
Cash and cash equivalents and restricted cash, end of period 262,590 428,688
Guarantor/Parent | Reportable Legal Entities    
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS    
Net cash (used in) provided by operating activities 2,188 10,776
Cash flows from investing activities:    
Capital expenditures (3,118) (2,189)
Payment for acquisition of business, net of cash acquired (2,781) (47,832)
Intercompany transfers 5,899 50,021
Cash flows from financing activities:    
Debt issuance costs paid (3,912)  
Intercompany transfers 78,122 76,503
Dividends paid (78,122) (76,503)
Payments for employee taxes on net settlement of equity awards (6,267) (5,471)
Proceeds from stock option exercises 1,954 892
Net cash used in financing activities (8,225) (4,579)
Net decrease in cash and cash equivalents and restricted cash (6,037) 6,197
Cash and cash equivalents and restricted cash, beginning of period 6,037 9,385
Cash and cash equivalents and restricted cash, end of period   15,582
Issuer Subsidiary | Reportable Legal Entities    
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS    
Net cash (used in) provided by operating activities 201,473 69,593
Cash flows from investing activities:    
Capital expenditures (191,210) (86,404)
Purchase of short-term investments (31,324) (16,183)
Proceeds from sale of short-term investments 31,860 18,120
Intercompany transfers (5,899) (50,021)
Proceeds from asset sales 8,227 8,022
Net cash used in investing activities (188,346) (126,466)
Cash flows from financing activities:    
Intercompany transfers (78,122) (76,503)
Net cash used in financing activities (78,122) (76,503)
Net decrease in cash and cash equivalents and restricted cash (64,995) (133,376)
Cash and cash equivalents and restricted cash, beginning of period 273,214 507,504
Cash and cash equivalents and restricted cash, end of period 208,219 374,128
Non-Guarantor Subsidiaries | Reportable Legal Entities    
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS    
Net cash (used in) provided by operating activities 5,821 (764)
Cash flows from investing activities:    
Capital expenditures (1,766) (3,105)
Proceeds from asset sales 3,382 727
Net cash used in investing activities 1,616 (2,378)
Cash flows from financing activities:    
Payment of contingent consideration from acquisition of business   (1,500)
Net cash used in financing activities   (1,500)
Net decrease in cash and cash equivalents and restricted cash 7,437 (4,642)
Cash and cash equivalents and restricted cash, beginning of period 46,934 43,620
Cash and cash equivalents and restricted cash, end of period $ 54,371 $ 38,978